1. Electrochemical/colorimetric dual-mode sensing strategy for cardiac troponin I detection based on zirconium nitride functionalized covalent organic frameworks.
- Author
-
Zhao, Hui, Zheng, Jing, Liang, Huan, Liu, Hui-Fang, Liu, Feng, Zhang, Ya-Ping, and Li, Can-Peng
- Subjects
- *
TROPONIN I , *ZIRCONIUM , *POLYANILINES , *CERIUM oxides , *MYOCARDIAL infarction , *PEPTIDES , *ENZYME-linked immunosorbent assay - Abstract
Cardiac troponin I (cTnI) is a gold-standard marker for the detection of acute myocardial infarction (AMI). Accurate and timely detection of cTnI is particularly important for AMI diagnosis and therapy. Herein, based on the dual-capacity (electro-catalysis and catalytic degradation) of PtPd@ZrN@COF to toluidine blue (TB), we developed novel electrochemical and enzyme-linked immunosorbent assay (ELISA) methods for ultrasensitive detection of cTnI. In the electrochemical sensor, polyaniline-coated cerium oxide loaded with gold nanoparticles (Au@PANI@CeO 2) were used as a substrate platform for immobilizing antibodies (Ab1), and PtPd@ZrN@COF loaded with the affinity peptide (Pep) of cTnI and TB (Pep/TB/PtPd@ZrN@COF) was the probe material for signal amplification of the sensor. Using the 'peptide-cTnI-Ab1′ sandwich biosensor, we successfully detected cTnI in a concentration range of 0.00001–50 ng·mL−1 with an ultralow detection limit (LOD) of 3.3 fg·mL−1. In addition, a sandwich ELISA was constructed by 96-well plate using Pep/PtPd@ZrN@COF as the probe molecule for cTnI detection, showing a detection range of 0.00001–5 ng·mL−1 and a LOD of 3.3 fg·mL−1. Both detection methods presented excellent accuracy, selectivity, reproducibility, and stability, providing a potential application in clinical diagnosis of AMI. [Display omitted] • An electrochemical/colorimetric dual-mode sensing strategy for cTnI was proposed. • The sensor was based on electro-catalysis and degradation of PtPd@ZrN@COF to TB. • The dual-mode sensor showed ultralow LOD of 3.3 fg mL−1 for cTnI. • The assay provided a potential detection for diagnosis of cardiovascular disease. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF